CSF2 and neoplasm: Studies on triple-negative breast cancer (TNBC) have shown that glycolysis restriction inhibits the expression of tumor colony-stimulating factors G-CSF and GM-CSF, thereby reducing the MDSC population, restoring anti-tumor T-cell immunity, reducing tumor growth and metastasis, and enhancing survival [215].